Inventor
SAMAJDAR SUSANTA
IN32 patents
⚠️ This page may combine multiple inventors who share the name “SAMAJDAR SUSANTA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AURIGENE DISCOVERY TECH LTD
13 patentsUS9732095B2Aug 15, 2017
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
AURIGENE DISCOVERY TECH LTD23 citations93
US10047104B2Aug 14, 2018
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
AURIGENE DISCOVERY TECH LTD11 citations92
US10160753B2Dec 25, 2018
Indazole compounds as IRAK4 inhibitors
AURIGENE DISCOVERY TECH LTD14 citations84
US11691987B2Jul 4, 2023
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
AURIGENE DISCOVERY TECH LTD3 citations83
US10995100B2May 4, 2021
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
AURIGENE DISCOVERY TECH LTD6 citations83
US10640517B2May 5, 2020
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
AURIGENE DISCOVERY TECH LTD6 citations83
US10689347B2Jun 23, 2020
Substituted heterocyclyl derivatives as CDK inhibitors
AURIGENE DISCOVERY TECH LTD4 citations82
US11865114B2Jan 9, 2024
Method for treating diseases using SMARCA2/4 degraders
AURIGENE DISCOVERY TECH LTD5 citations71
US11174232B2Nov 16, 2021
Substituted heterocyclyl derivatives as CDK inhibitors
AURIGENE DISCOVERY TECH LTD3 citations71
US11419875B2Aug 23, 2022
Compounds and compositions for treating hematological disorders
AURIGENE DISCOVERY TECH LTD5 citations64
US11186576B2Nov 30, 2021
Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitors
AURIGENE DISCOVERY TECH LTD1 citations60
US10894786B2Jan 19, 2021
Substituted pyrazole derivatives as selective CDK12/13 inhibitors
AURIGENE DISCOVERY TECH LTD0 citations51
US12371426B2Jul 29, 2025
Pyridazine derivatives as SMARCA2/4 degraders
AURIGENE DISCOVERY TECH LTD0 citations49
MITOBRIDGE INC
5 patentsUS10479775B1Nov 19, 2019
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
MITOBRIDGE INC7 citations83
US10399958B2Sep 3, 2019
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
MITOBRIDGE INC7 citations83
US11578052B2Feb 14, 2023
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
MITOBRIDGE INC1 citations72
US10906885B2Feb 2, 2021
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
MITOBRIDGE INC1 citations72
US10188627B2Jan 29, 2019
PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
MITOBRIDGE INC0 citations40
AURIGENE ONCOLOGY LTD
4 patentsUS11981685B2May 14, 2024
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
AURIGENE ONCOLOGY LTD1 citations72
US12410193B2Sep 9, 2025
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
AURIGENE ONCOLOGY LTD0 citations62
US12331023B2Jun 17, 2025
Substituted heterocyclyl derivatives as CDK inhibitors
AURIGENE ONCOLOGY LTD0 citations60
US12570650B2Mar 10, 2026
6-substituted pyridazine compounds as SMARCA2 and/or SMARCA4 degraders
AURIGENE ONCOLOGY LTD0 citations42
ORION CORP
3 patentsUS10077259B2Sep 18, 2018
Bicyclic heterocyclic derivatives as bromodomain inhibitors
ORION CORP2 citations70
US10336697B2Jul 2, 2019
Spiro[cyclobutane-1,3′-indolin]-2′-one derivatives as bromodomain inhibitors
ORION CORP6 citations69
US10590118B2Mar 17, 2020
Bicyclic heterocyclic derivatives as bromodomain inhibitors
ORION CORP0 citations49